These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11838631)

  • 1. Valproate-induced parkinsonism in a demented elderly patient.
    Iijima M
    J Clin Psychiatry; 2002 Jan; 63(1):75. PubMed ID: 11838631
    [No Abstract]   [Full Text] [Related]  

  • 2. [Reversible parkinsonism induced by prolonged treatment with valproate].
    Barroso B
    Therapie; 2002; 57(4):410-1. PubMed ID: 12422564
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnosis of Parkinsonism in older patients receiving sodium valproate.
    Macphee GJ; Stewart DA
    Mov Disord; 2007 Jun; 22(8):1211. PubMed ID: 17443705
    [No Abstract]   [Full Text] [Related]  

  • 4. Valproic acid-induced parkinsonism in the elderly: a comprehensive review of the literature.
    Mahmoud F; Tampi RR
    Am J Geriatr Pharmacother; 2011 Dec; 9(6):405-12. PubMed ID: 21993183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and management of aggressive behavior in the elderly demented patient.
    Raskind MA
    J Clin Psychiatry; 1999; 60 Suppl 15():45-9. PubMed ID: 10418815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium valproate in the treatment of behavioral disturbance in dementia.
    Mellow AM; Solano-Lopez C; Davis S
    J Geriatr Psychiatry Neurol; 1993; 6(4):205-9. PubMed ID: 8251047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reversible Parkinsonism and cognitive impairment following treatment with valproate].
    Toribio-Díaz ME; Morera-Guitart J; Palao-Duarte S
    Rev Neurol; 2008 Oct 1-15; 47(7):390-1. PubMed ID: 18841554
    [No Abstract]   [Full Text] [Related]  

  • 8. Valproate-induced parkinsonism: use of a newer pharmacovigilance tool to investigate the reporting of an unanticipated adverse event with an "old" drug.
    Hauben M; Reich L
    Mov Disord; 2005 Mar; 20(3):387. PubMed ID: 15641014
    [No Abstract]   [Full Text] [Related]  

  • 9. Valproate-induced Parkinsonism in epilepsy patients.
    Jamora D; Lim SH; Pan A; Tan L; Tan EK
    Mov Disord; 2007 Jan; 22(1):130-3. PubMed ID: 17115396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproate-induced parkinsonism, glial cells and Alexander's disease.
    Sechi GP; Conti M; Sau GF; Cocco GA
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1351-2. PubMed ID: 18495313
    [No Abstract]   [Full Text] [Related]  

  • 11. Valproate-induced rest tremor and parkinsonism.
    Baizabal-Carvallo JF; Alonso-Juarez M
    Acta Neurol Belg; 2021 Apr; 121(2):515-519. PubMed ID: 31721077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of severe parkinsonism in an elderly person induced by valproic acid.
    Tada H; Ogihara T; Nakamura T; Sasayama D; Sugiyama N; Takahashi Y; Washizuka S; Amano N
    Psychogeriatrics; 2017 Jan; 17(1):76-77. PubMed ID: 26757408
    [No Abstract]   [Full Text] [Related]  

  • 13. Movement disorders in patients taking anticonvulsants.
    Zadikoff C; Munhoz RP; Asante AN; Politzer N; Wennberg R; Carlen P; Lang A
    J Neurol Neurosurg Psychiatry; 2007 Feb; 78(2):147-51. PubMed ID: 17012337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Case report of sodium valproate treatment of aggression associated with Alzheimer's disease].
    Takahashi M; Akagi M
    No To Shinkei; 1996 Aug; 48(8):757-60. PubMed ID: 8797211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuropsychiatric symptoms caused by valproic acid].
    Andrade R; García-Espinosa A; Pérez-Montoto A; Toledo-Sotomayor G; Remón-González Y; Frades-García V
    Rev Neurol; 2010 Jan 1-15; 50(1):62-3. PubMed ID: 20073028
    [No Abstract]   [Full Text] [Related]  

  • 16. [Parkinsonism induced by sodium valproate].
    del Real Francia MA; Sanz Martínez J; Vaamonde Gamo J; Gudín Rodríguez-Magariños M; Ibáñez Alonso R; Riñón V
    Neurologia; 1995 Nov; 10(9):381-3. PubMed ID: 8554795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible Valproic Acid-Induced Parkinsonism and Cognitive Impairment in an Elderly Patient With Bipolar Disorder I.
    Hassamal S; Waller S; Reese K; Testa C
    Turk Psikiyatri Derg; 2016; 27(3):213-217. PubMed ID: 27711942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reversible dementia-like condition and parkinsonism in an elderly woman. Idiosyncratic adverse effects connected to 11 years of antiepileptic medication].
    Lindbom U; Taubert B; Fahlqvist MS; Bergens A; Kimland E; Jonsson EW; Bergman U
    Lakartidningen; 2009 Mar 18-24; 106(12):863-5. PubMed ID: 19452788
    [No Abstract]   [Full Text] [Related]  

  • 19. [Parkinsonism due to the medication].
    Louter M; Tromp SC
    Ned Tijdschr Geneeskd; 2009; 153():A336. PubMed ID: 19900308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease.
    Herrmann N; Lanctôt KL; Rothenburg LS; Eryavec G
    Dement Geriatr Cogn Disord; 2007; 23(2):116-9. PubMed ID: 17148938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.